Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

38.69USD
24 Jan 2017
Change (% chg)

$-0.23 (-0.59%)
Prev Close
$38.92
Open
$38.73
Day's High
$38.77
Day's Low
$38.51
Volume
1,530,718
Avg. Vol
3,628,802
52-wk High
$45.58
52-wk Low
$37.20

Latest Key Developments (Source: Significant Developments)

GlaxoSmithKline appoints Luke Miels President, Global Pharma
Thursday, 19 Jan 2017 02:09am EST 

Glaxosmithkline Plc : Luke Miels appointed president, global pharmaceuticals, gsk .Luke is currently executive vice president (evp) of astrazeneca's european business.  Full Article

GSK's pharmaceuticals president Abbas Hussain to leave in 2017
Thursday, 19 Jan 2017 02:05am EST 

Glaxosmithkline Plc :Abbas hussain, president, global pharmaceuticals has decided to leave company. He has agreed with gsk that he will leave company later this year.  Full Article

GSK's Viiv announces positive results from initial HIV phase III studies
Tuesday, 20 Dec 2016 02:00am EST 

Glaxosmithkline Plc : First phase iii studies to show efficacy of two-drug regimen as maintenance therapy .Viiv healthcare announces positive results from first phase iii studies of two-drug hiv treatment regimen.  Full Article

GSK files regulatory submission of candidate vaccine
Monday, 21 Nov 2016 06:30am EST 

GlaxoSmithKline Plc : GSK files regulatory submission of candidate vaccine for prevention of shingles in Canada .Says regulatory submission for candidate shingles vaccine is based on a comprehensive phase III clinical trial program.  Full Article

GSK files regulatory submission in U.S. for COPD treatment
Monday, 21 Nov 2016 02:11am EST 

Glaxosmithkline Plc : Files regulatory submission in US for once-daily closed triple combination therapy ff/umec/vi for patients with copd .This follows announcement earlier this year of plans to bring forward timing of us filing from first half of 2018..  Full Article

Fimbrion, GSK to develop novel antibacterial therapy for UTIs
Tuesday, 25 Oct 2016 09:45am EDT 

Fimbrion Therapeutics Inc:Fimbrion - co and GSK to develop novel antibacterial therapy for urinary tract infections.  Full Article

Glaxo to pay $20 mln to resolve SEC charges
Friday, 30 Sep 2016 02:15pm EDT 

GlaxoSmithKline PLC : SEC says GlaxoSmithKline PLC to pay $20 million to settle foreign corrupt practices act charges . SEC says civil penalty resolves charges that glaxo's China-based units engaged in pay-to-prescribe schemes to boost sales . SEC says glaxo did not admit or deny wrongdoing . SEC says glaxo's accounting controls failed to prevent schemes, and improper payments were not accurately reflected in its books.  Full Article

GlaxoSmithKline appoints new consumer healthcare CEO
Thursday, 29 Sep 2016 07:40am EDT 

GlaxoSmithKline Plc : GlaxoSmithKline plc appoints Brian McNamara as CEO of GSK consumer healthcare . McNamara succeeds Emma Walmsley who was last week appointed GSK CEO designate succeeding Sir Andrew Witty as GSK CEO . McNamara is currently head of Europe & Americas at GSK consumer healthcare Further company coverage: [GSK.L] (Bengaluru Newsroom) ((+91 806 749 1136;)).  Full Article

Aspen Pharmacare says GSK sells remaining stake in co
Thursday, 29 Sep 2016 03:05am EDT 

Aspen Pharmacare Holdings Ltd : GSK completed an accelerated bookbuild for disposal of its remaining shareholding in aspen .Disposal in no way affects ongoing collaboration between aspen and GSK in South Africa.  Full Article

GSK gets 477 mln stg gross proceeds from Aspen Pharmacare stake sale
Thursday, 29 Sep 2016 02:54am EDT 

Glaxosmithkline Plc :Gross proceeds of Aspen transaction are equivalent to £477 million.  Full Article

PRESS DIGEST- British Business - Jan 20

Jan 20 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.